312 related articles for article (PubMed ID: 31958323)
1. Laboratory based antimicrobial resistance surveillance for Pseudomonas aeruginosa blood isolates from South Africa.
Singh-Moodley A; Duse A; Naicker P; Kularatne R; Nana T; Lekalakala R; Mbelle N; Dawood H; Swe Swe Han K; Ramjathan P; Bhola P; Whitelaw A; Perovic O
J Infect Dev Ctries; 2018 Aug; 12(8):616-624. PubMed ID: 31958323
[TBL] [Abstract][Full Text] [Related]
2. Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil.
Xavier DE; Picão RC; Girardello R; Fehlberg LC; Gales AC
BMC Microbiol; 2010 Aug; 10():217. PubMed ID: 20704733
[TBL] [Abstract][Full Text] [Related]
3. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
[TBL] [Abstract][Full Text] [Related]
5. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa.
Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL
J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
Sader HS; Huband MD; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
[No Abstract] [Full Text] [Related]
9. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation of antimicrobial resistance in
Pragasam AK; Vijayakumar S; Bakthavatchalam YD; Kapil A; Das BK; Ray P; Gautam V; Sistla S; Parija SC; Walia K; Ohri VC; Anandan S; Veeraraghavan B
Indian J Med Microbiol; 2016; 34(4):433-441. PubMed ID: 27934820
[TBL] [Abstract][Full Text] [Related]
11. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
Int J Antimicrob Agents; 2017 Jun; 49(6):767-769. PubMed ID: 28392440
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Mohanty S; Maurya V; Gaind R; Deb M
J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
[TBL] [Abstract][Full Text] [Related]
13. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
[TBL] [Abstract][Full Text] [Related]
14. Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica.
Toval F; Guzmán-Marte A; Madriz V; Somogyi T; Rodríguez C; García F
J Med Microbiol; 2015 Jan; 64(Pt 1):37-43. PubMed ID: 25355933
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
17. Identification of plasmid OXA and other β-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the Clinical University Hospital in northeastern Poland.
Sacha P; Michalska A; Ojdana D; Wieczorek P; Hauschild T; Majewski P; Tryniszewska E
New Microbiol; 2015 Apr; 38(2):271-5. PubMed ID: 25938753
[TBL] [Abstract][Full Text] [Related]
18. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program.
Ribeiro J; Mendes RE; Domingos R; França E; Silbert S; Jones RN; Sader HS
J Chemother; 2006 Oct; 18(5):461-7. PubMed ID: 17127220
[TBL] [Abstract][Full Text] [Related]
19. Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among Coronavirus disease-19 patients.
Shiralizadeh S; Keramat F; Hashemi SH; Majzoobi MM; Azimzadeh M; Alikhani MS; Karami P; Rahimi Z; Alikhani MY
BMC Microbiol; 2023 Mar; 23(1):84. PubMed ID: 36991311
[TBL] [Abstract][Full Text] [Related]
20. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
